• Indications
  1. Severe, refractory COPD with Chronic Bronchitis and frequent exacerbations
  • Mechanism
  1. PDE3 and PDE4 Inhibitors increase lung, intracellular cAMP
  2. Bronchodilates and reduces airway inflammation
  • Medications
  1. Roflumilast (Daliresp) Tablets
  2. Ensifentrine (Ohtuvayre) nebulized